Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+88.0%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+88.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$260.99M+31.8%
2024$198.07M+391.5%
2023$-67.94M-273.0%
2022$39.27M-36.2%
2021$61.59M-